0001567619-20-015832.txt : 20200820
0001567619-20-015832.hdr.sgml : 20200820
20200820170100
ACCESSION NUMBER: 0001567619-20-015832
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200818
FILED AS OF DATE: 20200820
DATE AS OF CHANGE: 20200820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCKEON BRIAN P
CENTRAL INDEX KEY: 0001219445
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 201120698
MAIL ADDRESS:
STREET 1: IDEXX LABORATORIES
STREET 2: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
doc1.xml
FORM 4
X0306
4
2020-08-18
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001219445
MCKEON BRIAN P
ONE IDEXX DRIVE
WESTBROOK
ME
04092
0
1
0
0
Executive VP & CFO
Common Stock
2020-08-18
4
M
0
1880
53.185
A
51486
D
Common Stock
2020-08-18
4
M
0
1256
79.54
A
52732
D
Incentive Stock Option (right-to-buy)
53.185
2020-08-18
4
M
0
1880
D
2023-12-31
Common Stock
1880
0
D
Incentive Stock Option (right-to-buy)
79.54
2020-08-18
4
M
0
1256
D
2025-02-13
Common Stock
1256
0
D
Grant of option to buy 4,700 shares of Issuer common stock that vested in five annual installments beginning on January 1, 2015. The number of derivative securities reported as beneficially owned and price with respect to this option were adjusted to reflect a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015 (the "Stock Split").
Grant of option to buy 628 shares of Issuer common stock that vested on February 14, 2020. The number of derivative securities reported as beneficially owned and price with respect to this option were adjusted to reflect the Stock Split.
Not applicable.
/s/ Lily J. Lu, Attorney-in-Fact for Brian P. McKeon
2020-08-20